Loading...
XLON
TATE
Market cap3.28bUSD
Oct 09, Last price  
559.00GBP
1D
-0.09%
1Q
0.36%
Jan 2017
-32.28%
Name

Tate & Lyle PLC

Chart & performance

D1W1MN
XLON:TATE chart
P/E
25.50
P/S
1.23
EPS
0.22
Div yield, %
3.57%
Shrs. gr., 5y
2.14%
Rev. gr., 5y
10.62%
Revenues
2.01b
+15.55%
3,225,000,0002,867,000,0003,553,000,0002,533,000,0002,720,000,0003,088,000,0003,256,000,0002,754,000,0002,341,000,0002,355,000,0002,753,000,0002,710,000,0002,755,000,0002,882,000,0001,211,000,0001,375,000,0001,751,000,0001,647,000,0001,736,000,0002,006,000,000
Net income
97m
-32.17%
214,000,000194,000,00065,000,00015,000,000163,000,000305,000,000272,000,000273,000,00030,000,000163,000,000256,000,000265,000,000181,000,000245,000,000253,000,000236,000,000190,000,000188,000,000143,000,00097,000,000
CFO
238m
+45.12%
227,000,000162,000,000501,000,000522,000,000122,000,000231,000,000251,000,000286,000,000179,000,000188,000,000298,000,000286,000,000330,000,000385,000,000369,000,000103,000,00066,000,000208,000,000164,000,000238,000,000
Dividend
Jun 18, 202613.2 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilizers. They also supply nutritive sweeteners, such as high-fructose corn syrup and dextrose. Beyond food-related offerings, the company manufactures industrial starches for applications like paper, packaging, and adhesives, alongside acidulants like citric acid. Furthermore, they deal in various commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company's activities extend to treasury, insurance, and vital research and development services.

Related entities

Subsidiaries (20)
G.C. HAHN & CO. COOPERATIONSGESELLSCHAFT MBH
G.C. HAHN & CO. STABILISIERUNGSTECHNIK GMBH
TATE & LYLE BOLERAZ, S.R.O.
TATE & LYLE GLOBAL SHARED SERVICES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TATE & LYLE INGREDIENTS FRANCE
TATE & LYLE INSURANCE (GIBRALTAR) LIMITED
TATE & LYLE INTERNATIONAL FINANCE PLC
TATE & LYLE INVESTMENTS LIMITED
TATE & LYLE ITALIA S.P.A.
TATE & LYLE MOLD UK LIMITED
TATE & LYLE NETHERLANDS B.V.
TATE & LYLE POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TATE & LYLE SLOVAKIA, S.R.O.
TATE & LYLE SWEDEN AB
TATE & LYLE VENTURES LIMITED
CP KELCO ApS
CP KELCO GERMANY GMBH
CP KELCO UK LIMITED
Tate & Lyle Americas LLC
TATE & LYLE MEXICO S DE RL DE CV

Key people

Anthony Nicholas Hampton
Chief Executive Officer, Executive Director · since 2018
Jim Stutelberg
President - Primary Products · since 2017
Andrew Taylor
President - Innovation and Commercial Development · since 2017
Chief Human Resource Officer · since 2018
Rowan Adams
Executive Vice President - Corporate Affairs · since 2014
Lindsay Beardsell
Executive Vice President, General Counsel · since 2018
Chief Executive, Executive Director · since 2009
Imran Nawaz
Chief Financial Officer, Executive Director · since 2018
Company Secretary · since 2017
Kimberly Nelson
Non-Executive Director · since 2019
Paul A. Forman
Senior Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2012
Non-Executive Independent Director · since 2016
IPO date
Dec 09, 1938
Employees
3,604
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
5 MARBLE ARCH
LONDON, LND W1H 7EJ
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT